Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies. - Wikidata - awgldk - TriplyDB

Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies.

Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies.

http://www.wikidata.org/entity/Q41923524

about

ALK Signaling and Target Therapy in Anaplastic Large Cell Lymphoma Molecular characterization of WDCP, a novel fusion partner for the anaplastic lymphoma tyrosine kinase ALK Molecular biology of lung cancer Targeted therapies and immunotherapy in non-small-cell lung cancer Tyrosine Kinase Receptor Landscape in Lung Cancer: Therapeutical Implications Not all epidermal growth factor receptor mutations in lung cancer are created equal: Perspectives for individualized treatment strategy Recent Advances in Targetable Therapeutics in Metastatic Non-Squamous NSCLC Molecular Subtypes and Personalized Therapy in Metastatic Colorectal Cancer Gene aberrations for precision medicine against lung adenocarcinoma Patterns of Chromosomal Aberrations in Solid Tumors Differences in driver genes between smoking-related and non-smoking-related lung cancer in the Chinese population Targeted therapies for patients with advanced NSCLC harboring wild-type EGFR: what's new and what's enough MET inhibitors in combination with other therapies in non-small cell lung cancer Concise review: The Piwi-piRNA axis: pivotal beyond transposon silencing Genomic profiling of small-cell lung cancer: the era of targeted therapies From human genome to cancer genome: the first decade Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Adult lung stem cells and their contribution to lung tumourigenesis Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancer The minority report: targeting the rare oncogenes in NSCLC SEER cancer registry biospecimen research: yesterday and tomorrow Clinical tumor sequencing: opportunities and challenges for precision cancer medicine Advances of molecular subtype and targeted therapy of lung cancer Crystal structures of the JAK2 pseudokinase domain and the pathogenic mutant V617F Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer.ESR1 ligand-binding domain mutations in hormone-resistant breast cancer.ROS1 and ALK fusions in colorectal cancer, with evidence of intratumoral heterogeneity for molecular drivers.BRAF fusions define a distinct molecular subset of melanomas with potential sensitivity to MEK inhibition Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine.Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusions Activity of second-generation ALK inhibitors against crizotinib-resistant mutants in an NPM-ALK model compared to EML4-ALK.Prediction of response to anti-EGFR antibody-based therapies by multigene sequencing in colorectal cancer patients.NTRK1 fusions for the therapeutic intervention of Korean patients with colon cancer.The possibility of clinical sequencing in the management of cancer Targeted Therapies in Non-Small Cell Lung Cancer-Beyond EGFR and ALK Genomic profiling toward precision medicine in non-small cell lung cancer: getting beyond EGFR Inhibitors of the anaplastic lymphoma kinase Epidermal growth factor receptor (EGFR) mutation and personalized therapy in advanced nonsmall cell lung cancer (NSCLC)Characteristics of lung cancers harboring NRAS mutations Identification of selective inhibitors of RET and comparison with current clinical candidates through development and validation of a robust screening cascade.

P2860

Q21129306-B46E147E-3E84-4E41-A99F-7AE777217E76 Q24308008-DE742F33-38D0-474B-A318-1F831842C87B Q24606677-92A0757D-6615-4B81-9F99-B81D4B4FB90D Q26738986-E2D9E1B8-FF75-4E99-88FF-308870086A32 Q26741318-FA967F7E-C708-4CC9-8DB6-9B6946EC9DAA Q26744284-6C03D05D-9706-4766-B92B-4F3CA863E78B Q26747276-8D68B981-9567-4F7F-85F3-5AAE24E4A845 Q26747329-3CAA04E4-6F1B-4E67-ABC6-17B1C260EA42 Q26749348-383E1DC2-3A0E-4579-A9D5-299A37002982 Q26786127-1AF34428-4C29-42E3-8763-4C976591750A Q26786594-F885B09A-E283-49A0-9C74-AFFEC2B8D998 Q26799467-4BF248B9-C461-40D0-BE51-F1F803B39DEE Q26823203-B90269B5-7FB7-4892-8C3C-7518F68D1890 Q26824060-446D18DC-DA2F-42A5-82D1-1DFDAD362272 Q26826915-EFA4E9D9-C4DF-45F2-A6C5-987144682939 Q26827640-BD6B187A-7481-4CC0-8493-26C40324BFEC Q26828860-18605AA5-AC5D-4F22-A98E-F8A53B1AF51B Q26830034-9AA499E1-CC37-4A77-801A-730689D7C72D Q26851421-84AFA55E-5B02-4542-90ED-C68E7EF82D1E Q26851636-AC91678F-3ADB-49B7-986B-0841C0789125 Q26998744-E6CC92D9-811F-4AC7-BE5D-16501E9692B8 Q27027942-AF8A496B-723A-4488-9B30-9F1F6FE1D3DA Q27030813-FF95D436-0BA8-4546-B767-9021F167B679 Q27670859-FB02DF8B-B129-4B90-AAAB-549264E373EE Q27852601-7F32C4B4-C676-4443-9BDD-3CDB00EFBCAD Q27852637-06F3587E-9E41-40C1-9345-C9BA59F551DF Q27852699-52302BAE-CDDF-4936-8855-DF4372B53780 Q27852730-A94E1B80-CE39-467A-B5C4-BFCEA855A984 Q27853005-9279FE69-07DD-45C1-B4EA-1598138BEE75 Q27853012-825115B6-BA9D-4D85-A08A-FC97EF09BC2D Q27853136-6761095B-649F-4F06-9A98-60BF11EADC65 Q27853234-2B1613C1-B3A5-4E55-9F95-19DDEDF7257A Q27853306-20D3A5E2-B8A0-4B4C-84CB-F0D27AB6ABD1 Q28072144-B381D04C-EBAB-424F-95F2-820CF33488AB Q28083446-F2B373E3-E4FB-4221-9624-A49E77A71CEE Q28086993-1B8CF7D4-58CA-4FE0-973D-E963E6A24F46 Q28267124-B02BE114-3B70-47C4-8376-4A1658EE9631 Q28284519-408D8938-522F-451A-82CE-6FF915A8D21D Q28706226-80D46559-CFB1-4684-A465-D04D687E6BAA Q28830947-B1BD402C-DC80-462A-A240-A76077B5A79D

P2860

Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies.

http://www.wikidata.org/entity/Q41923524

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies.

@en

type

label

Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies.

@en

prefLabel

Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies.

@en

P1433

Q41923524-106F6F2E-ED6C-4CAE-B678-FAE76F59CE59

P1476

Q41923524-939C7FA8-EBA2-4FDA-844E-733E847125F4

P2093

Q41923524-005D50A0-F0C6-4F6D-B329-34EFC3B41B68

Q41923524-02BEA1FF-CFE6-420A-B36D-97D4AAE1D0A0

Q41923524-143BD63E-736C-4044-B182-09B886338D10

Q41923524-1A09794E-0328-47CF-A354-CCA66FB7B3A7

Q41923524-28231AAA-6343-4CF5-997F-975722A7018A

Q41923524-292BD247-4F9A-4C40-AC4E-7A91C7F843B9

Q41923524-2B0A17DE-29CA-4D9F-A5EB-E1CBBCAC3B4B

Q41923524-2F970455-C7C7-4653-91FB-1457F739F505

Q41923524-4C7E372D-95DA-475F-A961-8044B161EA6A

Q41923524-4CC906CB-4FE0-4F4E-8859-15293C352557

P2860

Q41923524-0058EC73-0E33-4455-9D9D-702E33969757

Q41923524-2CFDA26D-C38A-4D54-B4B2-A44A4D2751A1

Q41923524-33B7273D-1029-42FB-BD11-228E1402CAEC

Q41923524-390B52B0-CF4B-425E-9044-DD4C4E591936

Q41923524-5130A140-351A-4F50-AFF5-C8031BB27AF3

Q41923524-5668F990-2B10-453E-8B9D-140A5CCDB9ED

Q41923524-570F5B0E-E6D8-4B84-9F1C-1BFA434FC876

Q41923524-582A87AC-52EE-4E01-B736-A590DAD6DDED

Q41923524-5B0187DB-8111-402B-A4A3-5259F340DFD3

Q41923524-5BD30271-2022-417C-A75F-31173BF48DD3

P2888

Q41923524-684B1D2C-1F27-4A35-92EE-D2B4EC412364

P304

Q41923524-C3300338-22F2-4798-9217-8FFE14AF8C81

P31

Q41923524-3B1B3ED4-EB34-4D8C-A99A-5398EBA79093

P356

Q41923524-85215CE3-A5E0-4037-855E-3E5A0DD1B092

P407

Q41923524-1709CA59-1E7F-4941-9968-AE876F5AA7C3

P433

Q41923524-9D8D808E-DF45-4CC4-9485-F03F84B52715

P478

Q41923524-E4E2A2AB-101D-48E3-9790-E1A8C916A387

P50

Q41923524-3D2A3112-7EEA-4AA5-AF26-A67542E27418

P577

Q41923524-E9CACF9F-3F06-46B6-B382-DBC55D3A9656

P5875

Q41923524-D5EA4175-543F-4014-B47E-845A37B5C2D3

P698

Q41923524-34D23533-2E0E-4981-96B5-FE9A9418953B

P932

Q41923524-CF76DA8C-4015-4EB7-AE85-C810A7E17247

P356

P1433

Nature Medicine

P1476

Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies.

@en

P2093

Alex Parker

http://www.w3.org/2001/XMLSchema#string

Amy Donahue

http://www.w3.org/2001/XMLSchema#string

Christine E Sheehan

http://www.w3.org/2001/XMLSchema#string

Dalia Ercan

http://www.w3.org/2001/XMLSchema#string

Doron Lipson

http://www.w3.org/2001/XMLSchema#string

Emily White

http://www.w3.org/2001/XMLSchema#string

Frank Juhn

http://www.w3.org/2001/XMLSchema#string

Garrett M Frampton

http://www.w3.org/2001/XMLSchema#string

Geoff Otto

http://www.w3.org/2001/XMLSchema#string

Hidefumi Sasaki

http://www.w3.org/2001/XMLSchema#string

P2860

PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro

KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

Deregulation of the PI3K and KRAS signaling pathways in human cancer cells determines their response to everolimus

COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

In vivo activation of the p53 pathway by small-molecule antagonists of MDM2

KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.

Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer.

P2888

P304

382-384

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NM.2673

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-02-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221826051

http://www.w3.org/2001/XMLSchema#string

P698

22327622

http://www.w3.org/2001/XMLSchema#string

P932

3916180

http://www.w3.org/2001/XMLSchema#string